DMII

Drugs Made In America Acquisition II Corp. - Ordinary Shares (DMII)

About Drugs Made In America Acquisition II Corp. - Ordinary Shares (DMII)

Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in New York, NY.

Details

Daily high
$10.12
Daily low
$10.12
Price at open
$10.12
52 Week High
$10.20
52 Week Low
$9.86
Market cap
645.3M
Dividend yield
-
Volume
432
Avg. volume
32,417
P/E ratio
49.75

Drugs Made In America Acquisition II Corp. - Ordinary Shares News

Details

Daily high
$10.12
Daily low
$10.12
Price at open
$10.12
52 Week High
$10.20
52 Week Low
$9.86
Market cap
645.3M
Dividend yield
-
Volume
432
Avg. volume
32,417
P/E ratio
49.75